A new study by Dr Michael Holmes (UCL Epidemiology &
Public Health) and colleagues has casts doubt on the usefulness of a highly touted genetic
test for patients taking the popular anti-clotting drug Clopidogrel.
Read:
Forbes More: Wall Street Journal (£)
Close
